Clinical trial · Observational
A Micro/Nano Device for Exhaled Breath Analysis
NCT02123030CI-TRIAL-00052344completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Use of a microfabricated silicon device to concentrate ultra trace volatile organic compounds (VOCs) in human exhaled breath for quantitative analysis of VOCs.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Pulmonary Disease | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Experimental
- description
- patients with pulmonary disease; and, patients with known or suspected lung or other cancers
- label
- Control
- description
- healthy subjects (for example, family members of the patient or graduate students
Primary outcomes (1)
- measure
- Detection of disease related markers (biomarkers) from concentrated volatile organic compounds in breath samples
- timeFrame
- 1 day (After sample collection)
- description
- The concentrated volatile organic compounds in exhaled breath samples will be analyzed by statistical software for search for disease related markers (biomarkers).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * For controlled (healthy) subjects - we are seeking persons who do not have a known history of cancer or pulmonary disease. * Both smokers and nonsmokers are invited to participate as control subjects. * For experimental subjects, we are seeking persons with pulmonary disease but no known history of cancer, as identified by the investigators during routine clinic or office visits. * Additionally for experimental subjects, we are seeking persons with known or suspected lung or other cancers, as identified by the investigators during routine clinic or office visits. Exclusion Criteria:
References
Publications (0)
Data not yet available
No reference posted for this study.